This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Peter Bruenker: Patent Activity in Antibody Research
Introduction
Peter Bruenker is an inventor associated with Basel, Switzerland, and Roche Diagnostics GmbH. His listed patent concerns antibodies that bind to CD3 and FOLR1.
Latest Patents
Bruenker is credited with 1 patent: “ANTIBODIES BINDING TO CD3 AND FOLR1.” The title indicates research involving antibodies that target CD3 and FOLR1.
Career Highlights
The available information associates Bruenker’s patent activity with Roche Diagnostics GmbH. No further details about his role or career history were provided.
Collaborations
Martina Geiger and Christian Klein are identified as some of Bruenker’s coworkers. The supplied information does not specify their roles in the patent.
Conclusion
Peter Bruenker’s listed innovation is a patent on antibodies binding to CD3 and FOLR1, associated with Roche Diagnostics GmbH and his professional connections in Basel.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile